ConductScience.org, home

Paper · 42980665

Photoinactivation of multidrug-resistant Gram-positive bacteria isolated from dogs with otitis using tetra-cationic porphyrins bearing peripheral platinum(II) (3-PtTPyP) and palladium(II) (3-PdTPyP) complexes.

Voigt TFJ and 8 others. Curr Microbiol, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Photoinactivation of multidrug-resistant Gram-positive bacteria isolated from dogs with otitis using tetra-cationic porphyrins bearing peripheral platinum(II) (3-PtTPyP) and palladium(II) (3-PdTPyP) complexes. Papers, record 42980665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42980665

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Photoinactivation of multidrug-resistant Gram-positive bacteria isolated from dogs with otitis using tetra-cationic porphyrins bearing peripheral platinum(II) (3-PtTPyP) and palladium(II) (3-PdTPyP) complexes.
Journal
Curr Microbiol
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-06

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Voigt TFJTauana Fernanda Jantsch
2Martins EEduarda
3Navarini JJunior
4Lopes MGMatheus Gass
5de Souza PRPaulo Ricardo
6Iglesias BABernardo Almeida
7Vogel FSFFernanda Silveira Flores
8Gressler LTLetícia Trevisan
9Cargnelutti JFJuliana Felipettohttps://orcid.org/0000-0002-3160-3643

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gram-Positive BacteriaMajor topic
Drug Resistance, Multiple, BacterialMajor topic
PorphyrinsMajor topic
Anti-Bacterial AgentsMajor topic
PalladiumMajor topic
Photosensitizing AgentsMajor topic
Dog DiseasesMajor topic
Gram-Positive Bacterial InfectionsMajor topic
Otitis ExternaMajor topic
Animals
Dogs
Microbial Sensitivity Tests
Platinum

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,960,140Effect of ampicillin on adhesive properties of bacteria examined by atomic force microscopy.Micron2018https://conductscience.org/library/papers/29960140PubMed
232,890,692In vitro antimicrobial photodynamic therapy using tetra-cationic porphyrins against multidrug-resistant bacteria isolated from canine otitis.Photodiagnosis Photodyn Ther2020https://conductscience.org/library/papers/32890692PubMed
335,657,980Occurrence and characterization of methicillin-resistant Staphylococcus spp. in diseased dogs in Brazil.PLoS One2022https://conductscience.org/library/papers/35657980PubMed
439,272,321Can We Minimize the Risk of Dogs Developing Canine Otitis Externa?-A Retrospective Study on 321 Dogs.Animals (Basel)2024https://conductscience.org/library/papers/39272321PubMed
540,780,637Retrospective study on antimicrobial resistance in bacteria isolated from clinical infections in Dogs at a Brazilian Veterinary Teaching hospital.Top Companion Anim Med2025https://conductscience.org/library/papers/40780637PubMed
624,549,049Influence of external bacterial structures on the efficiency of photodynamic inactivation by a cationic porphyrin.Photochem Photobiol Sci2014https://conductscience.org/library/papers/24549049PubMed
731,277,423Application of Porphyrins in Antibacterial Photodynamic Therapy.Molecules2019https://conductscience.org/library/papers/31277423PubMed
832,400,785Photophysical, photodynamical, redox properties and BSA interactions of novel isomeric tetracationic peripheral palladium(II)-bipyridyl porphyrins.Dalton Trans2020https://conductscience.org/library/papers/32400785PubMed
942,165,985Antimicrobial photodynamic therapy using tetra-cationic porphyrins with peripheral platinum(II) and palladium(II) complexes against multidrug-resistant bacteria isolated from canine otitis.Photochem Photobiol Sci2026https://conductscience.org/library/papers/42165985PubMed
1037,448,771Evidence for the transmission of antimicrobial resistant bacteria between humans and companion animals: A scoping review.One Health2023https://conductscience.org/library/papers/37448771PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42980665

GET https://conductscience.org/api/papers/v1/42980665/references?page=2